Tnf Pharmaceuticals(Tnfa) Financials: Interest Coverage Compared To Industry Average, Plus Other Key Ratios

Report Profitability Growth Liquidity Solvency Valuation

debt to assets debt to equity equity multiplier financial leverage interest coverage

Solvency Trend (Last 5 Years)

Solvency - interest coverage

This chart shows the historical trend of interest coverage for TNFA compared to its industry average over the recent years.

Ratio Definition and Interpretation

Name: Interest Coverage

Definition: Interest coverage tells you how easily the company can pay interest on its debt using operating profits. It’s like asking: “Can the company comfortably make its loan payments, or is it barely scraping by?” The higher the ratio, the safer. A very low ratio means debt payments may strain the business, especially if profits drop.

Interpretation:
• In '2021', TNFA's interest coverage was -48.12, indicating the firm's ability to meet its interest obligations. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2021' stood at -3.73.
Overall, TNFA's interest coverage has been volatile but generally stable over the past 1 years.

Formula: Interest Coverage = EBIT / Interest Expense

Good Range: Minimum 3-5 desirable; below 1 is risky.